Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effects of N-Acetyl-L-Leucine on Niemann Pick Type C Disease: A Multinational, Multicenter, Open-label, Rater-blinded Phase II Study

Trial Profile

Effects of N-Acetyl-L-Leucine on Niemann Pick Type C Disease: A Multinational, Multicenter, Open-label, Rater-blinded Phase II Study

Status: Recruiting
Phase of Trial: Phase II

Latest Information Update: 05 Nov 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs L-Acetylleucine (Primary)
  • Indications Niemann-Pick disease type C
  • Focus Therapeutic Use
  • Sponsors IntraBio
  • Most Recent Events

    • 18 Sep 2019 According to an IntraBio media release, this trial has been accepted by Independent Ethics Committees (IEC), and the Spanish Agency of Medicines and Medical Products (AEMPS; EudraCT: 2018-004431-71) as well as National Regulatory Agencies in Germany, Slovakia, the United Kingdom, and the US Food and Drug Administration (IND 134369).
    • 18 Sep 2019 According to an IntraBio media release, this trial is open for recruitment in Slovakia at Comenius University in Bratislava.
    • 18 Sep 2019 According to an IntraBio media release, this trial is open for recruitment in Spain.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top